In several cancers, such as ovarian, breast, glioblastoma, squamous cell carcinoma (SCC), and NSCLC, CCL2 expression positively correlated with increased infiltration of tumor-associated macrophages (TAMs) [105]. Here, CCL2 is linked to cancer.